S. 2817 · 116th Congress
End Price Gouging for Insulin Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
MerkleySponsor1 cosponsor · 1 D
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.
What it does: CRS summary · Introduced in Senate · Nov 7, 2019
End Price Gouging for Insulin Act
This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: End Price Gouging for Insulin Act
Latest action (Nov 7, 2019): Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6479-6480)
Policy area: Health · Origin: Senate · Introduced: Nov 7, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.